AstraZeneca Plc Share EquityWhat's this? Price(GBX) 10,524.000.53%(56.00) AZNORD SHS $0.25 Track6 more instruments Open/Last close 10,520.00/10,524.00 High/Low 10,606.00/10,482.00 Bid/Offer 10,522.00/10,524.00 Special Condition:-
AstraZeneca PLC AZN:LSE Actions Health CarePharmaceuticals and Biotechnology Price (GBX)10,486.00 Today's Change-82.00 / -0.78% Shares traded476.00k 1 Year change+0.92% Beta0.3794 Data delayed at least 20 minutes, as of Dec 13 2024 13:51 GMT....
AstraZeneca PLC AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. ...
AstraZeneca PLC A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales...
AstraZeneca PLC Stock Price History Beta (5Y Monthly)0.194636 52-Week Change24.14% S&P500 52-Week Change20.43% 52 Week High153.1 USD 52 Week Low104.5 USD 50-Day Moving Average147.43 USD 200-Day Moving Average132.36 USD AZNCF Share Statistics ...
Get the latest AstraZeneca PLC (AZN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
AstraZeneca PLC Price AstraZeneca PLC price | AstraZeneca PLC Quote Zacks Rank & Key Picks AstraZeneca carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the overall healthcare sector include Arcturus Therapeutics ARCT, Bioventus BVS and Fulcrum Therapeutics FULC, each sporting a Zac...
AstraZeneca PLC (AZN) advanced chart and technical analysis tool allows you to add studies and indicators such as Moving Averages (SMA and EMA), MACD, On-Balance-Volume, and more.
In an indication of investor expectations of continued high growth, the ratio of AstraZeneca’s share price to earnings is 18.9 times — well ahead of rivals, with the exception of Novo Nordisk and Eli Lilly, which have been boosted by weight-loss drug sales. ...
1926:Imperial Chemical Industries (ICI, parent company of Zeneca PLC) founded in the UK. 1943:Astra develops Xylocane, which becomes the world's largest-selling local anesthetic. 1988:Hanakan Mogren appointed CEO of Astra AB. 1993:Zeneca PLC demerged from ICI. ...